FILE:CLX/CLX-8K-20041130181603.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)
[ ]  Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
ITEM 8.01  OTHER EVENTS
The information set forth in the Registrants press release regarding its proposed private placement of $1.65 billion aggregate principal amount of senior notes (the Notes), dated November 30, 2004, which is filed as exhibit 99.1 hereto, is incorporated herein by reference.
The information contained in this Current Report on Form 8-K is neither an offer to sell nor a solicitation of an offer to buy any of the Notes. The Notes to be offered will not be registered under the Securities Act of 1933, as amended (the Securities Act), or applicable state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.
SIGNATURES
ITEM 9.01  FINANCIAL  STATEMENTS AND EXHIBITS
(c)        Exhibits
             
Exhibit
Description
99.1                 Press Release, dated November 30, 2004.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
                                                                        THE CLOROX COMPANY
Date:  November 30, 2004                               By: /s/ PAMELA FLETCHER
                                                                                    Pamela Fletcher
                                                                                    Vice President - Secretary
                                                                                   
             
Exhibit
Description
99.1                 Press Release, dated November 30, 2004.
           
                                   



The Clorox Company
News Release
CLOROX ANNOUNCES PRICING OF $1.65 BILLION SENIOR NOTES
OAKLAND, Calif., Nov. 30, 2004  The Clorox Company (NYSE: CLX) (PCX: CLX) today announced that it has priced the offering of $1.65 billion aggregate principal amount of its senior notes in a private placement transaction.  The senior notes consist of $500 million aggregate principal amount of floating-rate senior notes due December 2007, $575 million aggregate principal amount of 4.20 percent senior notes due January 2010 and $575 million aggregate principal amount of 5.00 percent senior notes due January 2015. The floating-rate senior notes will bear interest at a rate equal to three-month LIBOR plus 0.125 percent, reset quarterly. The offering is expected to close on Dec. 3, 2004, subject to customary closing conditions.
 
Clorox stated that it intends to use the full amount of the net proceeds from the offering to repay a portion of the amount outstanding under its commercial-paper program used to finance the cash contribution it made in connection with its previously announced share exchange with Henkel KGaA.
 
The securities to be offered will not be registered under the Securities Act or applicable state securities laws or blue sky laws, and may not be offered or sold in the United States absent registration under the Securities Act and applicable state securities laws or available exemptions from the registration requirements. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the notes.
The statements in this press release regarding the timing of the proposed private placement and its terms are forward-looking statements that involve risks and uncertainties including, but not limited to, market conditions and the price and market for the securities to be offered.
Media Relations
Kathryn Caulfield (510) 271-7209
Dan Staublin (510) 271-1622
Investor Relations
Steve Austenfeld (510) 271-2270
Michael Iracondo (510) 271-2156


